Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Parathyroid Gland”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03011736
What this trial is testing

Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism

Who this might be right for
Parathyroid Gland AdenomaPrimary Hyperparathyroidism
Roswell Park Cancer Institute 6
Not applicableStudy completedNCT05426512
What this trial is testing

Effect of Mechanical Loading on vBMD and Geometry in Patients With Primary Hyperparathyroidism

Who this might be right for
Primary Hyperparathyroidism
EFSTATHIOS CHRONOPOULOS 120
Not applicableUnknownNCT04569513
What this trial is testing

The Analysis of Thyroidectomy and Parathyroidectomy

Who this might be right for
Thyroid DiseasesParathyroid Diseases
National Taiwan University Hospital 12,000
Not applicableUnknownNCT02273570
What this trial is testing

Optimal Anemia Treatment in End Stage Renal Disease (ERSD)

Who this might be right for
Hyperparathyroidism, Secondary
Azienda Ospedaliera Sant'Anna 50
Not applicableApproved For MarketingNCT05654701
What this trial is testing

Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism

Who this might be right for
Hypoparathyroidism
Ascendis Pharma Bone Diseases A/S
Not applicableNot Yet RecruitingNCT06804681
What this trial is testing

Is Intraoperative PTH Monitoring Obsolete in Times of Choline PET/CT? a Prospective Multicenter Cohort Study to Determine Whether the Regular Preoperative Use of Choline-PET/CT Scan Obviate the Need for Intraoperative PTH-measurement in Patients with Primary Hyperparathyreoidism

Who this might be right for
Primary Hyperparathyroidism
University of Zurich 1,000
Testing effectiveness (Phase 2)WithdrawnNCT01665651
What this trial is testing

Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy

Who this might be right for
Renal Insufficiency, ChronicRenal Osteodystrophy
Bing Shu
Not applicableStudy completedNCT04281875
What this trial is testing

Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.

Who this might be right for
Postoperative HypoparathyroidismThyroid NeoplasmsThyroid Cancer
Vanderbilt-Ingram Cancer Center 160
Testing effectiveness (Phase 2)Study completedNCT00005005
What this trial is testing

PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

Who this might be right for
Osteoporosis
Dennis Black 238
Not applicableLooking for participantsNCT07379463
What this trial is testing

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

Who this might be right for
Amino-Acid Transport DisorderPrimary HyperparathyroidismGlioma
Tianjin Medical University 500
Large-scale testing (Phase 3)Study completedNCT00037635
What this trial is testing

An Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 400
Post-approval studies (Phase 4)Study completedNCT00379899
What this trial is testing

ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseCoronary Artery Calcification+8 more
Amgen 360
Not applicableStudy completedNCT04053647
What this trial is testing

Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)

Who this might be right for
HypoparathyroidismQuality of Life
Nantes University Hospital 143
Testing effectiveness (Phase 2)Study completedNCT05149898
What this trial is testing

Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)

Who this might be right for
22Q11.2 Deletion Syndrome
Harmony Biosciences Management, Inc. 20
Not applicableStudy completedNCT01574287
What this trial is testing

Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas

Who this might be right for
Parathyroid Disease
David M. Schuster, MD 4
Testing effectiveness (Phase 2)Study completedNCT00172107
What this trial is testing

Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Shire 217
Not applicableStudy completedNCT05264610
What this trial is testing

Retrospective Analysis of the Effects of Perioperative Osteoanabolic Treatment on Patients With Spinal (Fusion) Surgery.

Who this might be right for
Spinal (Fusion) Surgery
University Hospital, Basel, Switzerland 40
Post-approval studies (Phase 4)Study completedNCT00288873
What this trial is testing

Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity

Who this might be right for
Vitamin D DeficiencySecondary HyperparathyroidismObesity
Weill Medical College of Cornell University 60
Testing effectiveness (Phase 2)Study completedNCT02216656
What this trial is testing

Phase 2 Study of KHK7580

Who this might be right for
Secondary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 201
Not applicableEnded earlyNCT04639960
What this trial is testing

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome

Who this might be right for
22q11.2 Deletion Syndrome
University of Geneva, Switzerland 16
Next Page